329 related articles for article (PubMed ID: 14533495)
1. [Thrombosis prophylaxis in orthopaedic surgery: considerations and uncertainties].
Ettema HB; Hoppener MR; Büller HR; Henny ChP; Verheyen CC
Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1842-7. PubMed ID: 14533495
[TBL] [Abstract][Full Text] [Related]
2. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
Whang PG; Lieberman JR
Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
[TBL] [Abstract][Full Text] [Related]
3. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
5. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
6. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
7. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
[TBL] [Abstract][Full Text] [Related]
8. Changes of D-dimer after total hip arthroplasty in patients with and without intraoperative heparin.
Maezawa K; Nozawa M; Aritomi K; Kubota M; Shitoto K; Kurosawa H
Arch Orthop Trauma Surg; 2008 Jan; 128(1):37-40. PubMed ID: 17522875
[TBL] [Abstract][Full Text] [Related]
9. Long-term cost-effectiveness of low molecular weight heparin versus unfractionated heparin for the prophylaxis of venous thromboembolism in elective hip replacement.
Marchetti M; Liberato NL; Ruperto N; Barosi G
Haematologica; 1999 Aug; 84(8):730-7. PubMed ID: 10458700
[TBL] [Abstract][Full Text] [Related]
10. [Thrombosis prevention in orthopaedic surgery: clinical practice in the Netherlands in 2002].
Schonenberg D; van Meeteren M; Nelissen RG; van der Horst-Bruinsma IE; Pöll RG; Nurmohamed MT
Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1856-60. PubMed ID: 14533499
[TBL] [Abstract][Full Text] [Related]
11. Prevention of venous thromboembolism in high-risk surgical and medical patients.
Prandoni P; Sabbion P; Tanduo C; Errigo G; Zanon E; Bernardi E
Semin Vasc Med; 2001; 1(1):61-70. PubMed ID: 15199515
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
[TBL] [Abstract][Full Text] [Related]
13. Deep vein thrombosis prophylaxis: a comprehensive approach for total hip and total knee arthroplasty patient populations.
Miric A; Lombardi P; Sculco TP
Am J Orthop (Belle Mead NJ); 2000 Apr; 29(4):269-74. PubMed ID: 10784014
[TBL] [Abstract][Full Text] [Related]
14. [Prophylaxis for deep vein thrombosis with low molecular weight heparin following hip and knee surgery].
Li XL; Lu WJ; Yu NS
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):39-41. PubMed ID: 12563929
[TBL] [Abstract][Full Text] [Related]
15. Rationale for low-molecular-weight heparin prophylaxis after total knee arthroplasty.
Colwell CW; Hardwick ME
Clin Orthop Relat Res; 2006 Nov; 452():181-5. PubMed ID: 17016231
[TBL] [Abstract][Full Text] [Related]
16. The role of low molecular weight heparin in total knee arthroplasty.
Iobst CA; Friedman RJ
Am J Knee Surg; 1999; 12(1):55-60. PubMed ID: 10050695
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of thromboprophylaxis in the management of total hip and knee arthroplasty.
Skinner HB; Schulz MM
Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):20-30. PubMed ID: 12349892
[TBL] [Abstract][Full Text] [Related]
18. Advances in DVT prophylaxis and management in major orthopaedic surgery.
Hardwick ME; Colwell CW
Surg Technol Int; 2004; 12():265-8. PubMed ID: 15455336
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgery.
Lassen MR; Borris LC
Curr Opin Pulm Med; 1996 Jul; 2(4):300-4. PubMed ID: 9363156
[TBL] [Abstract][Full Text] [Related]
20. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery.
Epstein NE
Surg Neurol; 2005 Oct; 64(4):295-301; discussion 302. PubMed ID: 16181995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]